利福平与利福喷汀治疗肺结核的临床疗效及不良反应对比研究OA
Clinical curative effects and adverse reactions of rifampicin versus rifapentine for lung tuberculosis
目的 探究与分析利福平与利福喷汀治疗肺结核的临床效果.方法 选取本院自2014年5月至2016年5月收治的90例肺结核患者,采取随机数字表法分为利福平组与利福喷汀组,各45例,对比两组临床疗效及不良反应.结果 利福平组临床有效率为77.78％,利福喷汀组为88.89％,差异具有统计学意义(P＜0.05).利福喷汀组痰涂片转阴率、空洞消失率及病灶吸收率均明显高于利福平组,差异具有统计学意义(均P＜ 0.05).利福平组不良反应发生率为33.33％,…查看全部>>
Objective To explore the clinical effects ofrifampicin and rifapentine for lung tuberculosis.Methods 90 patients with lung tuberculosis treated at our hospital from May,2014 to May,2016 were selected and divided into a rifampicin group and a rifapentine group using random number table,45 cases for each group.The clinical curative effect and adverse reactions were compared between these two groups.Results The clinical effective rate was 77.78％ in the ri…查看全部>>
丁瑞东
251700 滨州市结核病防治院结核三科
利福平利福喷汀肺结核抗菌活性不良反应
RifampicinRifapentineLung tuberculosisAntimicrobial activityAdverse reactions
《国际医药卫生导报》 2017 (9)
1407-1409,3
评论